Back
Axcelis Technologies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
61
ACLS
Axcelis Technologies
Last Price:
137.76
Seasonality Move:
-1.02%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Buy
61
Axcelis Technologies (ACLS)
is a Buy
Is Axcelis Technologies a Buy, Sell or Hold?
- The current Axcelis Technologies [ACLS] share price is $137.76. The Score for ACLS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- ACLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACLS Stock Price Chart
What is Axcelis Technologies's stock price today?
-
The Axcelis Technologies share price today is $137.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.60
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.38 | Buy |
Relative Strength Index (14 RSI): | 67.36 | Buy |
Chaikin Money Flow: | 473925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (111.52 - 134.04) | Buy |
Bollinger Bands (100): | (104.09 - 124.95) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 45.77 | Sell |
Chaikin Money Flow: | 722527 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.99 - 42.29) | Sell |
Bollinger Bands (100): | (41.03 - 48.83) | Sell |
ACLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 137.14 | Buy |
20-day SMA: | 125.09 | Buy |
50-day SMA: | 114.19 | Buy |
200-day SMA: | 127.75 | Buy |
8-day EMA: | 135.53 | Buy |
20-day EMA: | 128.06 | Buy |
50-day EMA: | 119.78 | Buy |
200-day EMA: | 123.47 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.38 | Sell |
20-day SMA: | 40.41 | Sell |
50-day SMA: | 41.94 | Sell |
200-day SMA: | 42.46 | Sell |
8-day EMA: | 39.76 | Sell |
20-day EMA: | 40.54 | Sell |
50-day EMA: | 42.03 | Sell |
200-day EMA: | 43.46 | Sell |
Axcelis Technologies Earnings Growth & ACLS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.43 per share, a decrease this year of $1.25 per share, and an increase next year of $1.98 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Axcelis Technologies Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |